Literature DB >> 19915632

Cerebral angiitis in four patients with chronic GVHD.

P Sostak1, C S Padovan, S Eigenbrod, S Roeber, S Segerer, C Schankin, S Siegert, T Saam, D Theil, H-J Kolb, H Kretzschmar, A Straube.   

Abstract

There is growing evidence that GVHD affects the central nervous system (CNS). In this study, we describe the long-term follow-up of four allogeneic BM recipients who developed cerebral angiitis-like disease probably due to GVHD. The patients developed focal neurological signs, cognitive deficits and/or coma in association with GVHD, 2-18 years after transplantation, following reduction of immunosuppressive therapy. Magnetic resonance imaging was variable, showing generalized brain atrophy, ischemic lesions or leukoencephalopathy. Diagnosis of cerebral angiitis was confirmed by histopathological analysis of bioptic brain tissue and response to immunosuppressive therapy. By means of immunohistochemistry and immunofluorescence, perivascular lymphomononuclear cerebral infiltrates were shown to express the adhesion receptor, CD11a, and the chemokine receptor, CCR5. Our findings imply that GVHD should be considered in the differential diagnosis of noninfectious angiitis-like disease of the CNS in long-term survivors after allogeneic BMT. Infiltrating cells, in analogy to typical target organs of GVHD such as skin or liver, expressed CD11a and CCR5. These findings could be of etiopathological, diagnostic and therapeutic relevance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915632     DOI: 10.1038/bmt.2009.323

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  22 in total

1.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; S J Lee; M Aljurf; Y Atsuta; C Bonfim; L J Burns; N Chaudhri; S Davies; S Okamoto; A Seber; G Socie; J Szer; M T Van Lint; J R Wingard; A Tichelli
Journal:  Hematol Oncol Stem Cell Ther       Date:  2012

2.  Bilateral Inflammatory Optic Neuropathy Related to Graft versus Host Disease Following Allogeneic Bone Marrow Transplantation for Hodgkin Disease.

Authors:  I Moesen; D P Kidd
Journal:  Neuroophthalmology       Date:  2014-07-22

Review 3.  Brain miliary enhancement.

Authors:  Joseph C J Bot; Linda Mazzai; Rogier E Hagenbeek; Silvia Ingala; Bob van Oosten; Esther Sanchez-Aliaga; Frederik Barkhof
Journal:  Neuroradiology       Date:  2020-01-10       Impact factor: 2.804

4.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; S J Lee; M Aljurf; Y Atsuta; C Bonfim; L J Burns; N Chaudhri; S Davies; S Okamoto; A Seber; G Socie; J Szer; M T Van Lint; J R Wingard; A Tichelli
Journal:  Bone Marrow Transplant       Date:  2012-03       Impact factor: 5.483

5.  The central nervous system is a target of acute graft versus host disease in mice.

Authors:  Steffen Hartrampf; Jarrod A Dudakov; Linda K Johnson; Odette M Smith; Jennifer Tsai; Natalie V Singer; Mallory L West; Alan M Hanash; Michael H Albert; Bingfang Liu; Miklos Toth; Marcel R M van den Brink
Journal:  Blood       Date:  2013-01-08       Impact factor: 22.113

6.  Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interaction.

Authors:  Nora Mirza; Manfred Zierhut; Andreas Korn; Antje Bornemann; Wichard Vogel; Barbara Schmid-Horch; Wolfgang A Bethge; Stefan Stevanović; Helmut R Salih; Lothar Kanz; Hans-Georg Rammensee; Sebastian P Haen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-10       Impact factor: 11.205

Review 7.  Neurologic Complications of Transplantation.

Authors:  Rajat Dhar
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

8.  Successful treatment of meningeal graft-versus-host disease in a haematopoietic stem cell transplant recipient.

Authors:  Victoria Pechey; John Parratt; Linh Vo; William Stevenson
Journal:  Int J Hematol       Date:  2014-11-22       Impact factor: 2.490

9.  [Complications after allogeneic bone marrow and stem cell transplantation].

Authors:  E Wollmer; A Neubauer
Journal:  Internist (Berl)       Date:  2014-05       Impact factor: 0.743

10.  Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT.

Authors:  Martin Schmidt-Hieber; Dan Engelhard; Andrew Ullmann; Per Ljungman; Johan Maertens; Rodrigo Martino; Montserrat Rovira; Peter J Shaw; Christine Robin; Maura Faraci; Jenny Byrne; Kerstin Schäfer-Eckart; Hermann Einsele; Edgar Faber; Luigi Rigacci; Riccardo Saccardi; Aitana Balaguer-Rosello; Cecilia Isaksson; Maximilian Christopeit; Gloria Tridello; Junfeng Wang; Nina Knelange; Malgorzata Mikulska; Simone Cesaro; Jan Styczynski
Journal:  J Neurol       Date:  2019-10-29       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.